Hormonal contraceptives and the length of their use are not independent risk factors for high-risk HPV infections or high-grade CIN

Gynecologic and Obstetric Investigation

Volumn 71, Issue 2, 2011, Pages 93-103

  Longatto Filho, Adhemar ^a,b   Hammes, Luciano Serpa ^c   Sarian, Luis Otavio ^d   Roteli Martins, Cecília ^e   Derchain, Sophie F M ^d   Eren, Mojca ^f   Branca, Margherita ^g   Tatti, Sílvio ^h   Naud, Paulo ^c   De Matos, Jean Carlos ^c   Gontijo, Renata ^d   Maeda, Marina Y S ^b   Lima, Temístocles ^e   Costa, Silvano ⁱ   Syrjänen, Stina ^j   Syrjänen, Kari ^k  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e HOSPITAL MATERNIDADE LEONOR MENDES DE BARROS   (Brazil)

^f SIZE Diagnostic Center   (Slovenia)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^h HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

^j UNIVERSITY OF TURKU   (Finland)

^k TURKU UNIVERSITY HOSPITAL   (Finland)

more..

Author keywords

Cervical intraepithelial lesions; Cohort study; High risk human papillomavirus; Hormonal contraceptives

Indexed keywords

CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARGENTINA; ARTICLE; BRAZIL; CANCER GRADING; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING; TREATMENT DURATION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VAGINA RING; WART VIRUS;

ADOLESCENT; ADULT; AGED; ARGENTINA; BRAZIL; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; CONTRACEPTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79952441671     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320742     Document Type: Article

References (22)

1. Castellsagué X, Muñoz N: Chapter 3: cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. Natl Cancer Inst Monogr 2003; 31: 20-28.
2. Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, Franceschi S, Beral V: Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 2003; 361: 1159-1167. (Pubitemid 36401593)
3. Bosch FX, de Sanjosé S: The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 2007; 23: 213-227. (Pubitemid 47015785)
4. Peto J, Gilham C, Fletcher O, Matthews FE: The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004; 364: 249-256. (Pubitemid 38942814)
5. Syrjänen K, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grunberga V, Grunberg A, Juschenko A, Santopietro R, Cintorino M, Tosi P, Syrjanen S: Oral contraceptives are not an independent risk factor for cervical intraepithelial neoplasia or high-risk human papillomavirus infections. Anticancer Res 2006; 26: 4729-4740. (Pubitemid 46032105)
6. Syrjänen S, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grunberga V, Grunberg A, Juschenko A, Cintorino M, Santopietro R, Tosi P, Syrjänen K: Factors predicting persistence of highrisk human papillomavirus (HPV) infections in women prospectively followed-up in three New Independent States (NIS) of the former Soviet Union. Eur J Gynaecol Oncol 2005; 26: 491-498. (Pubitemid 41585929)
7. Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJ, Walboomers JM: Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994; 69: 114-119. (Pubitemid 24021832)
8. Rousseau MC, Franco EL, Villa LL, Sobrinho JP, Termini L, Prado JM, Rohan TE: A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections. Cancer Epidemiol Biomarkers Prev 2000; 9: 469-476. (Pubitemid 30313889)
9. Yang BH, Bray FI, Parkin DM, Sellors JW, Zhang ZF: Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer 2004; 109: 418-424. (Pubitemid 38252771)
10. Syrjänen K Naud P, Derchain SM, Roteli- Martins C, Longatto-Filho A, Tatti S, Branca M, Eržen M, Serpa-Hammes L, Matos J, Gontijo R, Sarian L, Lima TP, Maeda MYS, Lörincz A, Dores GB, Costa S, Syrjänen S: Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS Study. Anticancer Res 2005; 25: 3469-3480. (Pubitemid 41105226)
11. Longatto-Filho A, Maeda MYS, Eržen M, Branca M, Roteli-Martins C, Naud P, Derchain SM, Serpa-Hammes L, Matos J, Gontijo R, Sarian L, Lima TP, Tatti S, Syrjänen S, Syrjänen K: Conventional PAP smear and liquid-based cytology as screening tools in low-resource settings of Latin America. Experience of the Latin American Screening Study. Acta Cytol 2005; 49: 500-506. (Pubitemid 41331079)
12. Sarian L Derchain SM, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Eržen M, Serpa-Hammes L, Matos J, Gontijo R, Lima TP, Maeda MYS, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K: Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI) cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin American Screening) study. J Med Screen 2005; 12: 142-149. (Pubitemid 41337147)
13. Longatto-Filho A, Eržen M, Branca M, Roteli- Martins C, Naud P, Derchain S, Hammes L, Sarian LO, Matos J, Gontijo R, Lima T, Maeda MYS, Tatti S, Syrjänen S, Dores G, Lörincz A, Syrjänen K: Human papillomavirus (HPV) testing as an optional screening tool in low-resource settings of Latin America. Experience from the LAMS Study. Int J Gynecol Cancer 2006; 16: 955-962. (Pubitemid 43886710)
14. Longatto-Filho A, Roteli-Martins C, Hammes L, Etlinger D, Pereira SM, Eržen M, Branca M, Naud P, Derchain, SF, Sarian LO, Matos J, Gontijo R, Lima T, Maeda MY, Tatti S, Syrjänen S, Syrjänen K: Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option. Experience from the LAMS Study. Eur J Gynaecol Oncol 2008; 29: 327-332.
15. Hammes LS, Naud P, Passos E, Rivoire W, Matos J, Brouwers K, Syrjänen KJ: Value of the International Federation of Colposcopy and Cervical Pathology (IFCPC) terminology in predicting cervical pathology. J Lower Genital Tract Dis 2007; 11: 158-165. (Pubitemid 47014187)
16. Solomon D, Nayar R: The Bethesda system for reporting cervical cytology: definitions, criteria and explanatory notes, ed 2. New York, Springler Verlag, 2004, pp 1-190.
17. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de González A, Colin D, Franceschi S, Goodhill A, Green J, Peto J, Plummer M, Sweetland S: Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007; 370: 1609-621.
18. Sasieni P: Cervical cancer prevention and hormonal contraception. Lancet 2007; 370: 1591-1592. (Pubitemid 350052277)
19. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de González A, Colin D, Franceschi S, Goodill A, Green J, Peto J, Plummer M, Sweetland S: Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006; 118: 1481-1495.
20. Vessey M, Painter R: Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004. Br J Cancer 2006; 95: 385-389. (Pubitemid 44187603)
21. Moreno V, Bosch FX, Muñoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S: International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 2002; 359: 1085-1092. (Pubitemid 34270731)
22. Vaccarella S, Herrero R, Dai M, Snijders PJ, Meijer CJ, Thomas JO, Hoang Anh PT, Ferreccio C, Matos E, Posso H, de Sanjosé S, Shin HR, Sukvirach S, Lazcano-Ponce E, Ronco G, Rajkumar R, Qiao YL, Muñoz N, Franceschi S: Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006; 15: 2148-2153. (Pubitemid 44877039)